Literature DB >> 16958001

Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis.

Waleed M Alazmi1, Arie Regev, Enrique G Molina, Eugene R Schiff.   

Abstract

It is estimated that 43% of patients with nonalcoholic steatohepatitis (NASH) will progress to liver fibrosis or cirrhosis. Although NASH is more common in Hispanics, most studies have been conducted on Caucasians, and there is scarce information regarding ethnic differences in this disease. The aim of this study was to identify the independent predictors of cirrhosis in Hispanic patients with NASH. A retrospective case-control study was conducted on 80 patients with biopsy-proven NASH. Forty-two were Hispanic (study group) and 38 were Caucasians controlled for age and BMI (control group). Clinical, biochemical, and histologic features were analyzed for correlation with cirrhosis. There were no significant differences in demographic features between the two groups. In multivariate analysis, independent predictors of cirrhosis among Hispanic patients were age (OR, 1.07; 95% CI, 1.01-1.14) and AST/ALT ratio (OR, 10.56; 95% CI; 2.46-45.29), while independent predictors among non-Hispanic patients were age (OR, 1.085; 95% CI, 1.0-1.186), and diabetes mellitus (OR, 6.46; 95% CI, 1.19-35.07). In patients with NASH, predictors of cirrhosis varied according to ethnic background. Age was an independent predictor in both groups, however, AST/ALT ratio was found to be an independent predictor of cirrhosis only in Hispanic patients, and diabetes mellitus only in non-Hispanic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958001     DOI: 10.1007/s10620-005-9065-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Total and regional body composition across age in healthy Hispanic and white women of similar socioeconomic status.

Authors:  Y G Casas; B C Schiller; C A DeSouza; D R Seals
Journal:  Am J Clin Nutr       Date:  2001-01       Impact factor: 7.045

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity.

Authors:  C García-Monzón; E Martín-Pérez; O L Iacono; M Fernández-Bermejo; P L Majano; A Apolinario; E Larrañaga; R Moreno-Otero
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

4.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

5.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 7.  Diabetes mellitus, obesity, and hepatic steatosis.

Authors:  Wael Youssef; Arthur J McCullough
Journal:  Semin Gastrointest Dis       Date:  2002-01

8.  Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management.

Authors:  A Y el-Hassan; E M Ibrahim; F A al-Mulhim; A A Nabhan; M Y Chammas
Journal:  Br J Radiol       Date:  1992-09       Impact factor: 3.039

9.  Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.

Authors:  S Bellentani; C Tiribelli; G Saccoccio; M Sodde; N Fratti; C De Martin; G Cristianini
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  5 in total

1.  Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004.

Authors:  Young-Hee Yoon; Hsiao-ye Yi; Patricia C Thomson
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

Review 2.  Chronic liver disease in the Hispanic population of the United States.

Authors:  Andres F Carrion; Ravi Ghanta; Olveen Carrasquillo; Paul Martin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-12       Impact factor: 11.382

Review 3.  Health disparities in the Latino population.

Authors:  William A Vega; Michael A Rodriguez; Elisabeth Gruskin
Journal:  Epidemiol Rev       Date:  2009-08-27       Impact factor: 6.222

4.  Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis.

Authors:  Hideki Fujii; Masaru Enomoto; Wakaba Fukushima; Satoko Ohfuji; Mami Mori; Sawako Kobayashi; Shuji Iwai; Hiroyasu Morikawa; Akihiro Tamori; Hiroki Sakaguchi; Yoshihiro Ikura; Makiko Ueda; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2009-04-10       Impact factor: 7.527

Review 5.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Authors:  Raj Vuppalanchi; Naga Chalasani
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.